<ul>
<li>2026 年将主导的三大投资主题</li>
</ul>
<p>根据 MarketBeat 的股票筛选工具，今天值得关注的七只医疗股票是联合健康集团、强生、Medline、直觉外科、麦克森、Hims &amp; Hers Health 和 Cencora。医疗股票是指涉及医疗和健康相关行业的公司的股票——包括制药、生物技术、医疗设备制造商、医院和医疗服务以及保险公司——其收入依赖于药物开发、患者护理、医疗技术和报销政策。对于投资者而言，这些股票通常被视为防御性和增长导向的混合，能够在经济下行时提供需求韧性，但也面临如监管批准、专利悬崖和临床试验结果等特定行业风险。这些公司在过去几天内的医疗股票交易量最高。</p>
<p>获取 <strong>联合健康集团</strong> 的提醒：</p>
<h2>联合健康集团 (UNH)</h2>
<p>联合健康集团公司在美国作为一家多元化的医疗保健公司运营。该公司通过四个部门运营：联合医疗、Optum Health、Optum Insight 和 Optum Rx。联合医疗部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务；提供医疗补助计划、儿童健康保险和医疗保健项目；以及为经济困难、医疗服务不足和没有雇主资助医疗保险的州项目提供健康和牙科福利、医院和临床服务，以及医疗保健福利产品和服务。</p>
<ul>
<li>5 只医疗股票值得关注，行业轮动已全面展开</li>
</ul>
<p>阅读我们关于 UNH 的最新研究报告</p>
<h2>强生 (JNJ)</h2>
<p>强生是一家控股公司，专注于医疗领域产品的研究、开发、制造和销售。它通过创新药物和医疗技术两个部门运营。创新药物部门专注于免疫学、传染病、神经科学、肿瘤学、心血管和代谢以及肺动脉高压。</p>
<ul>
<li>Snowflake 股票火爆——现在买入仍不算晚</li>
</ul>
<p>阅读我们关于 JNJ 的最新研究报告</p>
<h2>Medline (MDLN)</h2>
<p>我们的使命是通过提供改善的临床、财务和运营结果来提升医疗保健的效率。我们是最大的医疗外科（“med-surg”）产品和供应链解决方案提供商，服务于所有护理点，基于医疗外科产品的总净销售额。我们提供在医院、手术中心、医生办公室和后期护理设施等各种护理环境中每日使用的关键产品。</p>
<p>阅读我们关于 MDLN 的最新研究报告</p>
<h2>直觉外科 (ISRG)</h2>
<p>直觉外科公司开发、制造和销售产品，使医生和医疗提供者能够提高美国及国际上微创护理的质量和可及性。该公司提供达芬奇手术系统，能够以微创方式进行复杂手术；以及 Ion 内腔系统，扩展其商业产品到诊断程序，使微创活检在肺部得以实现。</p>
<p>阅读我们关于 ISRG 的最新研究报告</p>
<h2>麦克森 (MCK)</h2>
<p>麦克森公司在美国和国际上提供医疗服务。它通过四个部门运营：美国制药、处方技术解决方案（RxTS）、医疗外科解决方案和国际业务。美国制药部门分销品牌药、仿制药、特种药、生物类似药和非处方药，以及其他与医疗相关的产品。</p>
<p>阅读我们关于 MCK 的最新研究报告</p>
<h2>Hims &amp; Hers Health (HIMS)</h2>
<p>Hims &amp; Hers Health 公司运营一个远程医疗咨询平台。它将消费者与医疗专业人员连接，使他们能够获得心理健康、性健康、皮肤病和初级护理的医疗服务。该公司成立于 2017 年，总部位于加利福尼亚州旧金山。</p>
<p>阅读我们关于 HIMS 的最新研究报告</p>
<h2>Cencora (COR)</h2>
<p>Cencora 公司采购和分销药品。该公司的美国医疗解决方案部门向急性护理医院和健康系统、独立和连锁零售药房、邮购药房、医疗诊所、长期护理和替代地点药房及其他客户分销药品、非处方医疗产品、家庭医疗用品和设备及相关服务；提供药房管理、人员配备和其他咨询服务；向零售和机构医疗提供者提供供应管理软件；向各种机构和零售医疗提供者提供包装解决方案；临床试验支持、产品批准后和商业化支持服务；为生物技术和制药制造商提供数据分析、结果研究和其他服务；向伴侣动物和生产动物市场提供药品、疫苗、驱虫剂、诊断、微饲料成分和其他产品；以及向制造商提供销售团队服务。</p>
<p>阅读我们关于 COR 的最新研究报告</p>
<h2>了解更多</h2>
<ul>
<li>MarketBeat 在 2025 年 12 月的五大股票推荐</li>
<li>Dollar General 的转机可能会推动股票在 2026 年上涨</li>
<li>不要对 AppLovin 下赌注：反对空头的理由</li>
<li>美光第一季度业绩表明 “人工智能泡沫远未破裂”</li>
<li>3 只便宜的分红股票可以战胜通货膨胀并支付你等待的费用</li>
<li>3 只可能在 2026 年扭转局面的新年决议股票</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在联合健康吗？</h2>
<p>在考虑联合健康之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而联合健康并不在名单上。</p>
<p>虽然联合健康目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

联合健康

直觉外科

MDLN

HIMS

<p>MarketBeat 的股票筛选工具突出了七只值得关注的医疗保健股票：联合健康集团、强生、Medline、直觉外科、麦克森、Hims & Hers Health 和 Cencora。这些公司最近的交易金额最高，涉及多个医疗保健领域，提供了防御性和成长型投资机会的组合</p>

<ul>
<li>The Top 3 Investment Themes That Will Dominate 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>2026 年将主导的三大投资主题</li>
</ul>
</div><p>UnitedHealth Group, Johnson &amp; Johnson, Medline, Intuitive Surgical, McKesson, Hims &amp; Hers Health, and Cencora are the seven Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of companies involved in medical and health-related industries — including pharmaceuticals, biotechnology, medical-device makers, hospitals and healthcare services, and insurers — whose revenues depend on drug development, patient care, medical technology and reimbursement policies. For investors, these stocks are often viewed as a mix of defensive and growth-oriented plays, offering demand resilience in downturns but carrying sector-specific risks like regulatory approvals, patent cliffs and clinical trial outcomes. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.</p>
<div class="lb-trans"><p>根据 MarketBeat 的股票筛选工具，今天值得关注的七只医疗股票是联合健康集团、强生、Medline、直觉外科、麦克森、Hims &amp; Hers Health 和 Cencora。医疗股票是指涉及医疗和健康相关行业的公司的股票——包括制药、生物技术、医疗设备制造商、医院和医疗服务以及保险公司——其收入依赖于药物开发、患者护理、医疗技术和报销政策。对于投资者而言，这些股票通常被视为防御性和增长导向的混合，能够在经济下行时提供需求韧性，但也面临如监管批准、专利悬崖和临床试验结果等特定行业风险。这些公司在过去几天内的医疗股票交易量最高。</p>
</div><p>Get <strong>UnitedHealth Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>联合健康集团</strong> 的提醒：</p>
</div><h2>UnitedHealth Group (UNH)</h2>
<div class="lb-trans"><h2>联合健康集团 (UNH)</h2>
</div><p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p>
<div class="lb-trans"><p>联合健康集团公司在美国作为一家多元化的医疗保健公司运营。该公司通过四个部门运营：联合医疗、Optum Health、Optum Insight 和 Optum Rx。联合医疗部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务；提供医疗补助计划、儿童健康保险和医疗保健项目；以及为经济困难、医疗服务不足和没有雇主资助医疗保险的州项目提供健康和牙科福利、医院和临床服务，以及医疗保健福利产品和服务。</p>
</div><ul>
<li>5 Healthcare Names to Watch as Sector Rotation Is in Full Swing</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只医疗股票值得关注，行业轮动已全面展开</li>
</ul>
</div><p>Read Our Latest Research Report on UNH</p>
<div class="lb-trans"><p>阅读我们关于 UNH 的最新研究报告</p>
</div><h2>Johnson &amp; Johnson (JNJ)</h2>
<div class="lb-trans"><h2>强生 (JNJ)</h2>
</div><p>Johnson &amp; Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.</p>
<div class="lb-trans"><p>强生是一家控股公司，专注于医疗领域产品的研究、开发、制造和销售。它通过创新药物和医疗技术两个部门运营。创新药物部门专注于免疫学、传染病、神经科学、肿瘤学、心血管和代谢以及肺动脉高压。</p>
</div><ul>
<li>Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>Snowflake 股票火爆——现在买入仍不算晚</li>
</ul>
</div><p>Read Our Latest Research Report on JNJ</p>
<div class="lb-trans"><p>阅读我们关于 JNJ 的最新研究报告</p>
</div><h2>Medline (MDLN)</h2>
<div class="lb-trans"><h2>Medline (MDLN)</h2>
</div><p>Our mission is to make healthcare run better by delivering improved clinical, financial, and operational outcomes. We are the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. We deliver mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities.</p>
<div class="lb-trans"><p>我们的使命是通过提供改善的临床、财务和运营结果来提升医疗保健的效率。我们是最大的医疗外科（“med-surg”）产品和供应链解决方案提供商，服务于所有护理点，基于医疗外科产品的总净销售额。我们提供在医院、手术中心、医生办公室和后期护理设施等各种护理环境中每日使用的关键产品。</p>
</div><p>Read Our Latest Research Report on MDLN</p>
<div class="lb-trans"><p>阅读我们关于 MDLN 的最新研究报告</p>
</div><h2>Intuitive Surgical (ISRG)</h2>
<div class="lb-trans"><h2>直觉外科 (ISRG)</h2>
</div><p>Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.</p>
<div class="lb-trans"><p>直觉外科公司开发、制造和销售产品，使医生和医疗提供者能够提高美国及国际上微创护理的质量和可及性。该公司提供达芬奇手术系统，能够以微创方式进行复杂手术；以及 Ion 内腔系统，扩展其商业产品到诊断程序，使微创活检在肺部得以实现。</p>
</div><p>Read Our Latest Research Report on ISRG</p>
<div class="lb-trans"><p>阅读我们关于 ISRG 的最新研究报告</p>
</div><h2>McKesson (MCK)</h2>
<div class="lb-trans"><h2>麦克森 (MCK)</h2>
</div><p>McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.</p>
<div class="lb-trans"><p>麦克森公司在美国和国际上提供医疗服务。它通过四个部门运营：美国制药、处方技术解决方案（RxTS）、医疗外科解决方案和国际业务。美国制药部门分销品牌药、仿制药、特种药、生物类似药和非处方药，以及其他与医疗相关的产品。</p>
</div><p>Read Our Latest Research Report on MCK</p>
<div class="lb-trans"><p>阅读我们关于 MCK 的最新研究报告</p>
</div><h2>Hims &amp; Hers Health (HIMS)</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health (HIMS)</h2>
</div><p>Hims &amp; Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health 公司运营一个远程医疗咨询平台。它将消费者与医疗专业人员连接，使他们能够获得心理健康、性健康、皮肤病和初级护理的医疗服务。该公司成立于 2017 年，总部位于加利福尼亚州旧金山。</p>
</div><p>Read Our Latest Research Report on HIMS</p>
<div class="lb-trans"><p>阅读我们关于 HIMS 的最新研究报告</p>
</div><h2>Cencora (COR)</h2>
<div class="lb-trans"><h2>Cencora (COR)</h2>
</div><p>Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.</p>
<div class="lb-trans"><p>Cencora 公司采购和分销药品。该公司的美国医疗解决方案部门向急性护理医院和健康系统、独立和连锁零售药房、邮购药房、医疗诊所、长期护理和替代地点药房及其他客户分销药品、非处方医疗产品、家庭医疗用品和设备及相关服务；提供药房管理、人员配备和其他咨询服务；向零售和机构医疗提供者提供供应管理软件；向各种机构和零售医疗提供者提供包装解决方案；临床试验支持、产品批准后和商业化支持服务；为生物技术和制药制造商提供数据分析、结果研究和其他服务；向伴侣动物和生产动物市场提供药品、疫苗、驱虫剂、诊断、微饲料成分和其他产品；以及向制造商提供销售团队服务。</p>
</div><p>Read Our Latest Research Report on COR</p>
<div class="lb-trans"><p>阅读我们关于 COR 的最新研究报告</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>MarketBeat's Top Five Stocks to Own in December 2025</li>
<li>Dollar General's Turnaround Could Send the Stock Higher in 2026</li>
<li>Don’t Bet Against AppLovin: The Case Against the Shorts</li>
<li>Micron’s Q1 Results Say “AI Bubble Is Far From Bursting”</li>
<li>3 Cheap Dividend Stocks That Can Beat Inflation and Pay You to Wait</li>
<li>3 New Year’s Resolution Stocks That Could Turn Around in 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 在 2025 年 12 月的五大股票推荐</li>
<li>Dollar General 的转机可能会推动股票在 2026 年上涨</li>
<li>不要对 AppLovin 下赌注：反对空头的理由</li>
<li>美光第一季度业绩表明 “人工智能泡沫远未破裂”</li>
<li>3 只便宜的分红股票可以战胜通货膨胀并支付你等待的费用</li>
<li>3 只可能在 2026 年扭转局面的新年决议股票</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在联合健康吗？</h2>
</div><p>Before you consider UnitedHealth Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑联合健康之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而联合健康并不在名单上。</p>
</div><p>While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然联合健康目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

12 月 18 日值得关注的最佳医疗保健股票